Current UConn projects are advancing bioscience
UConn Health is launching a program that uses convalescent plasma from employees who have recovered from COVID-19 to administer to patients suffering from the illness...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
UConn Health is launching a program that uses convalescent plasma from employees who have recovered from COVID-19 to administer to patients suffering from the illness...
Biohaven has announced that it is partnering with Cove, a company focused on providing specialized care and access for patients with migraine, particularly through telemedicine....
Yale University researchers will begin a clinical trial at Yale-New Haven Hospital to test the effectiveness of a drug called ibudilast (MN-166) for treating acute...
In 2019, the UConn Technology Incubation Program (TIP) continued to grow, as captured by key metrics, which indicate the overall health and success of its resident...
The New Haven Plan Commission has approved Yale New Haven Health’s plan for a new neuroscience center and expansion at its St. Raphael campus. The...
New Haven has reached a tentative development agreement that would pave the way for a transformative $100 million life-sciences incubator in the heart of downtown...
Yale University has signed on to a set of technology licensing principles designed to incentivize and allow for broad and equitable access to university innovations...
Tangen Biosciences is developing a rapid diagnostic test for use on the Tangen GeneSparkTM molecular diagnostic system to detect the SARS-CoV-2 virus, with results available...
How is your company addressing the challenges posed by COVID-19? Your feedback is critical and will help direct the response from the Governor and state Department...
Alexion Pharmaceuticals plans to initiate a global Phase 3 study to investigate ULTOMIRIS® (ravulizumab-cwvz) in a subset of adults with COVID-19 – those who are...